HighTower Advisors’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

HighTower Advisors’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-193,645	Closed	-$249K	–	2008
2016 Q2	$249K	Sell	193,645 -2,230	-1%	-$3.57K	﹤0.01%	1402
2016 Q1	$257K	Sell	195,875 -320	-0.2%	-$381	﹤0.01%	1686
2015 Q4	$279K	Buy	196,195 +3,000	+2%	+$4.82K	﹤0.01%	1600
2015 Q3	$298K	Sell	193,195 -183,560	-49%	-$292K	﹤0.01%	1459
2015 Q2	$640K	Buy	+376,755	New	+$629K	0.01%	934

Other funds holding ECTE

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $107M AUM 37.25% 1-Year Est. Return

HighTower Advisors's ECTE Position: Q3 2016 in Review

HighTower Advisors sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2016, closing a stake of 193,645 shares — an estimated $249K sold.

HighTower Advisors first reported a position in ECTE in Q2 2015 and held it in 5 quarters. The position peaked at $640K in Q2 2015. 2 funds tracked by Wall St. Rank hold ECTE as of Q3 2016.

HighTower Advisors reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2016 after selling out during the quarter.
HighTower Advisors sold 193,645 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2016, an estimated $249K.
HighTower Advisors first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2015 and held it in 5 quarters.
HighTower Advisors's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $640K in Q2 2015.
2 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2016.

Based on HighTower Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.